West nile virus infections

People with certain medical conditions, such as cancer, diabetes, hypertension, kidney disease, and people who have received organ transplants, are also at greater risk. Recovery from severe illness might take several weeks or months. Some effects to the central nervous system might be permanent. About 1 out of 10 people who develop severe illness affecting the central nervous system die. Diagnosis See your healthcare provider if you develop the symptoms described above.

Your healthcare provider can order tests to look for West Nile virus infection. To learn more about testing, visit our Healthcare Providers page. Supportive care remains the mainstay treatment for West Nile virus infections. West Nile Virus Doctor Discussion Guide Get our printable guide for your next doctor's appointment to help you ask the right questions. Download PDF.

Email the Guide Send to yourself or a loved one. Sign Up. How is West Nile virus diagnosed? When should you seek treatment for West Nile virus?

These include: Severe headache Stiff neck High fever Muscles weakening or giving out suddenly. Was this page helpful? Thanks for your feedback! What are your concerns? Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy. Prevention Ulbert S. Vaccine ; Vector Borne Zoonotic Dis ; Antivir Chem Chemother ; Related Articles.

Encephalitis vs. What Are the Different Types of Encephalitis? Infections That Cause Headaches and a Fever. Essential role of cyclization sequences in flavivirus RNA replication. Kilpatrick AM. Globalization, land use, and the invasion of West Nile virus. Host heterogeneity dominates West Nile virus transmission.

Kilpatrick AM, et al. West Nile virus risk assessment and the bridge vector paradigm. West Nile virus epidemics in North America are driven by shifts in mosquito feeding behavior. PLoS Biol. King NJ, et al. Immunopathology of flavivirus infections. Cell Biol. Klein RS, et al. Kokoza V, et al. Engineering blood meal-activated systemic immunity in the yellow fever mosquito, Aedes aegypti.

Komar N, et al. Kong KF, et al. Phylogeny of the genus Flavivirus. Kusne S, Smilack J. Transmission of West Nile virus by organ transplantation. Liver Transpl. Lanciotti RS, et al. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Lanteri MC, et al. Comprehensive analysis of West Nile virus-specific T cell responses in humans. Tregs control the development of symptomatic West Nile virus infection in humans and mice.

Beta interferon controls West Nile virus infection and pathogenesis in mice. Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses. Li J, et al. Asymmetric flaccid paralysis: a neuromuscular presentation of West Nile virus infection. Lim JK, et al. Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic.

CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmission. Chemokine receptor Ccr2 is critical for monocyte accumulation and survival in West Nile virus encephalitis. Keratinocytes are cell targets of West Nile virus in vivo. Lin CW, et al. Molecular biology of flaviviruses. Lindenbach DR, CM Lindsey NP, et al. West Nile virus activity—United States, Delayed mortality in a cohort of persons hospitalized with West Nile virus disease in Colorado in Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription.

Liu WJ, et al. Genetic variants and susceptibility to neurological complications following West Nile virus infection. Luplertlop N, et al. Induction of a peptide with activity against a broad spectrum of pathogens in the Aedes aegypti salivary gland, following infection with dengue virus. West Nile encephalitis: an emerging disease in the United States. McGee CE, et al. Infection, dissemination, and transmission of a West Nile virus green fluorescent protein infectious clone by Culex pipiens quinquefasciatus mosquitoes.

McMeniman CJ, et al. Stable introduction of a life-shortening Wolbachia infection into the mosquito Aedes aegypti. The impact of transgenic mosquitoes on dengue virulence to humans and mosquitoes.

Mehlhop E, Diamond MS. Protective immune responses against West Nile virus are primed by distinct complement activation pathways. Mehlhop E, et al. Complement protein C1q reduces the stoichiometric threshold for antibody-mediated neutralization of West Nile virus. Complement activation is required for induction of a protective antibody response against West Nile virus infection. Structure of the dengue virus envelope protein after membrane fusion.

Characterization of the functional requirements of West Nile virus membrane fusion. Host feeding patterns of Culex mosquitoes and West Nile virus transmission, northeastern United States. Molina-Cruz A, et al. Effect of mosquito midgut trypsin activity on dengue-2 virus infection and dissemination in Aedes aegypti. Munoz-Jordan JL, et al. Murray K, et al. Risk factors for encephalitis and death from West Nile virus infection.

Persistent infection with West Nile virus years after initial infection. The virology, epidemiology, and clinical impact of West Nile virus: a decade of advancements in research since its introduction into the Western Hemisphere. Nash D, et al. Oliphant T, et al. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus.

Olson KE, et al. Developing arbovirus resistance in mosquitoes. Insect Biochem. Genetically engineered resistance to dengue-2 virus transmission in mosquitoes. Persistence of West Nile virus immunoglobulin M antibodies, Greece. Parsons R, et al. Pesko K, Mores CN. Effect of sequential exposure on infection and dissemination rates for West Nile and St.

Louis encephalitis viruses in Culex quinquefasciatus. West Nile virus: a primer for the clinician. Piazza P, et al. Surface phenotype and functionality of WNV specific T cells differ with age and disease severity. Pinto AK, et al. Pogodina VV, et al. Study on West Nile virus persistence in monkeys. Persistence of antibodies to West Nile virus nonstructural protein 5. Puig-Basagoiti F, et al.

Triaryl pyrazoline compound inhibits flavivirus RNA replication. Agents Chemother. Qian F, et al. Impaired interferon signaling in dendritic cells from older donors infected in vitro with West Nile virus. Ramamoorthi N, et al. The Lyme disease agent exploits a tick protein to infect the mammalian host. Ramirez JL, Dimopoulos G. The Toll immune signaling pathway control conserved anti-dengue defenses across diverse Ae. Migratory birds and spread of West Nile virus in the Western Hemisphere.

Avian host and mosquito Diptera: Culicidae vector competence determine the efficiency of West Nile and St. Louis encephalitis virus transmission. Vector competence of Culiseta incidens and Culex thriambus for West Nile virus.

Cultivation of various arboviruses in new transplantable lines of mouse fibroblasts. Ribeiro JM. Blood-feeding in mosquitoes: probing time and salivary gland anti-haemostatic activities in representatives of three genera Aedes, Anopheles, Culex. Ribeiro JM, et al. An annotated catalogue of salivary gland transcripts in the adult female mosquito, Aedes aegypti.

BMC Genomics 8 :6 doi: Simulium vittatum Diptera: Simuliidae and Lutzomyia longipalpis Diptera: Psychodidae salivary gland hyaluronidase activity. The salivary adenosine deaminase activity of the mosquitoes Culex quinquefasciatus and Aedes aegypti. Platelet-activating-factor-hydrolyzing phospholipase C in the salivary glands and saliva of the mosquito Culex quinquefasciatus. Aedes aegypti: model for blood finding strategy and prediction of parasite manipulation. Role of mosquito saliva in blood vessel location.

The salivary purine nucleosidase of the mosquito, Aedes aegypti. Rice CM. Rios JJ, et al. OAS1 polymorphisms are associated with susceptibility to West Nile encephalitis in horses. Rios M, et al. Monocytes-macrophages are a potential target in human infection with West Nile virus through blood transfusion. Transfusion 46 — [ PubMed ] [ Google Scholar ]. Effect of the Aedes fluviatilis saliva on the development of Plasmodium gallinaceum infection in Gallus gallus domesticus.

Rodenhuis-Zybert IA, et al. Immature dengue virus: a veiled pathogen? Roehrig JT, et al. Persistence of virus-reactive serum immunoglobulin m antibody in confirmed West Nile virus encephalitis cases. Samuel MA, et al. PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons.

Sangiambut S, et al. Multiple regions in dengue virus capsid protein contribute to nuclear localization during virus infection. Differential expression of interferon IFN regulatory factors and IFN-stimulated genes at early times after West Nile virus infection of mouse embryo fibroblasts. Schneider BS, Higgs S. The enhancement of arbovirus transmission and disease by mosquito saliva is associated with modulation of the host immune response.

Schneider BS, et al. Prior exposure to uninfected mosquitoes enhances mortality in naturally-transmitted West Nile virus infection.

PLoS One 2 :e doi: Aedes aegypti saliva alters leukocyte recruitment and cytokine signaling by antigen-presenting cells during West Nile virus infection.

Potentiation of West Nile encephalitis by mosquito feeding. Sejvar JJ, et al. Neurologic manifestations and outcome of West Nile virus infection.

Sessions OM, et al. Discovery of insect and human dengue virus host factors. The peritrophic matrix of hematophagous insects. Early induction of interferon-independent virus-specific ICAM-1 CD54 expression by flavivirus in quiescent but not proliferating fibroblasts—implications for virus-host interactions. Biochemistry 35 — [ PubMed ] [ Google Scholar ]. Shrestha B, Diamond MS. Shrestha B, et al. Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection.

Tumor necrosis factor alpha protects against lethal West Nile virus infection by promoting trafficking of mononuclear leukocytes into the central nervous system. Siddharthan V, et al. Persistent West Nile virus associated with a neurological sequela in hamsters identified by motor unit number estimation. Sim S, Dimopoulos G. Skip directly to site content Skip directly to page options Skip directly to A-Z link.

West Nile virus. Section Navigation. Facebook Twitter LinkedIn Syndicate.